Related Experiment Video
Updated: May 27, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma
David Herrero-Martin1, Argyro Fourtouna, Stephan Niedan
1Children's Cancer Research Institute, St Anna Kinderkrebsforschung, 1090 Vienna, Austria.
Ewing's sarcoma family tumors (ESFT) are driven by EWS-ETS proteins resulting from chromosomal translocations. Understanding factors affecting these proteins is key to developing new therapies for this deadly cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ewing's sarcoma family tumors (ESFT) are rare but aggressive cancers.
- Specific chromosomal translocations are hallmarks of ESFT, leading to the formation of EWS-ETS chimeric proteins.
- These chimeric proteins act as aberrant transcription factors, driving tumor development.
Purpose of the Study:
- To identify factors that regulate the expression and activity of EWS-ETS chimeric proteins.
- To lay the groundwork for novel therapeutic strategies targeting the molecular drivers of ESFT.
Main Methods:
- The study likely involved molecular biology techniques to analyze gene expression and protein activity.
- Methods may include genetic analysis, cell culture experiments, and biochemical assays.
Main Results:
- The research identified specific molecular pathways or factors influencing EWS-ETS protein function.
- Results provide insights into the oncogenic mechanisms of ESFT.
Conclusions:
- Targeting EWS-ETS expression or activity presents a promising therapeutic avenue for ESFT.
- Further research into these regulatory factors could lead to effective treatments for this fatal disease.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
Mitogens and the Cell Cycle

